☰

Bronwyn M. Gunn, Ph.D. - Publications

Affiliations: 
2013 Microbiology & Immunology University of North Carolina, Chapel Hill, Chapel Hill, NC 
Area:
Virology Biology, Immunology
Tree Info Similar researchers PubMed Report error

31 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Fox JM, Roy V, Gunn BM, Bolton GR, Fremont DH, Alter G, Diamond MS, Boesch AW. Enhancing the therapeutic activity of hyperimmune IgG against chikungunya virus using FcγRIIIa affinity chromatography. Frontiers in Immunology. 14: 1153108. PMID 37251375 DOI: 10.3389/fimmu.2023.1153108  0.324
2023 Bukreyev A, Ilinykh P, Huang K, Gunn B, Kuzmina N, Gilchuk P, Alter G, Crowe J. Antiviral protection by antibodies targeting the glycan cap of Ebola virus glycoprotein requires activation of the complement system. Research Square. PMID 37131834 DOI: 10.21203/rs.3.rs-2765936/v1  0.308
2022 Seifert SN, Bai S, Fawcett S, Norton EB, Zwezdaryk KJ, Robinson J, Gunn B, Letko M. An ACE2-dependent Sarbecovirus in Russian bats is resistant to SARS-CoV-2 vaccines. Plos Pathogens. 18: e1010828. PMID 36136995 DOI: 10.1371/journal.ppat.1010828  0.306
2020 Ilinykh PA, Huang K, Santos RI, Gilchuk P, Gunn BM, Karim MM, Liang J, Fouch ME, Davidson E, Parekh DV, Kimble JB, Pietzsch CA, Meyer M, Kuzmina NA, Zeitlin L, et al. Non-neutralizing Antibodies from a Marburg Infection Survivor Mediate Protection by Fc-Effector Functions and by Enhancing Efficacy of Other Antibodies. Cell Host & Microbe. PMID 32320678 DOI: 10.1016/J.Chom.2020.03.025  0.341
2019 Gunn BM, Roy V, Karim MM, Hartnett JN, Suscovich TJ, Goba A, Momoh M, Sandi JD, Kanneh L, Andersen KG, Shaffer JG, Schieffelin JS, Garry RF, Grant DS, Alter G. Survivors of Ebola virus disease develop polyfunctional antibody responses. The Journal of Infectious Diseases. PMID 31301137 DOI: 10.1093/Infdis/Jiz364  0.342
2019 Fox JM, Roy V, Gunn BM, Huang L, Edeling MA, Mack M, Fremont DH, Doranz BJ, Johnson S, Alter G, Diamond MS. Optimal therapeutic activity of monoclonal antibodies against chikungunya virus requires Fc-FcγR interaction on monocytes. Science Immunology. 4. PMID 30796092 DOI: 10.1126/Sciimmunol.Aav5062  0.407
2019 Bornholdt ZA, Herbert AS, Mire CE, He S, Cross RW, Wec AZ, Abelson DM, Geisbert JB, James RM, Rahim MN, Zhu W, Borisevich V, Banadyga L, Gunn BM, Agans KN, et al. A Two-Antibody Pan-Ebolavirus Cocktail Confers Broad Therapeutic Protection in Ferrets and Nonhuman Primates. Cell Host & Microbe. 25: 49-58.e5. PMID 30629918 DOI: 10.1016/J.Chom.2018.12.005  0.372
2019 Wec AZ, Bornholdt ZA, He S, Herbert AS, Goodwin E, Wirchnianski AS, Gunn BM, Zhang Z, Zhu W, Liu G, Abelson DM, Moyer CL, Jangra RK, James RM, Bakken RR, et al. Development of a Human Antibody Cocktail that Deploys Multiple Functions to Confer Pan-Ebolavirus Protection. Cell Host & Microbe. 25: 39-48.e5. PMID 30629917 DOI: 10.1016/J.Chom.2018.12.004  0.317
2018 Saphire EO, Schendel SL, Gunn BM, Milligan JC, Alter G. Antibody-mediated protection against Ebola virus. Nature Immunology. 19: 1169-1178. PMID 30333617 DOI: 10.1038/S41590-018-0233-9  0.334
2018 Ilinykh PA, Santos RI, Gunn BM, Kuzmina NA, Shen X, Huang K, Gilchuk P, Flyak AI, Younan P, Alter G, Crowe JE, Bukreyev A. Asymmetric antiviral effects of ebolavirus antibodies targeting glycoprotein stem and glycan cap. Plos Pathogens. 14: e1007204. PMID 30138408 DOI: 10.1371/Journal.Ppat.1007204  0.335
2018 Gunn BM, Yu WH, Karim MM, Brannan JM, Herbert AS, Wec AZ, Halfmann PJ, Fusco ML, Schendel SL, Gangavarapu K, Krause T, Qiu X, He S, Das J, Suscovich TJ, et al. A Role for Fc Function in Therapeutic Monoclonal Antibody-Mediated Protection against Ebola Virus. Cell Host & Microbe. 24: 221-233.e5. PMID 30092199 DOI: 10.1016/J.Chom.2018.07.009  0.32
2018 Gilchuk P, Kuzmina N, Ilinykh PA, Huang K, Gunn BM, Bryan A, Davidson E, Doranz BJ, Turner HL, Fusco ML, Bramble MS, Hoff NA, Binshtein E, Kose N, Flyak AI, et al. Multifunctional Pan-ebolavirus Antibody Recognizes a Site of Broad Vulnerability on the Ebolavirus Glycoprotein. Immunity. PMID 30029854 DOI: 10.1016/J.Immuni.2018.06.018  0.311
2018 Luke T, Bennett RS, Gerhardt DM, Burdette T, Postnikova E, Mazur S, Honko AN, Oberlander N, Byrum R, Ragland D, St Claire M, Janosko KB, Smith G, Glenn G, Hooper J, ... ... Gunn B, et al. Fully Human Immunoglobulin G From Transchromosomic Bovines Treats Nonhuman Primates Infected With Ebola Virus Makona Isolate. The Journal of Infectious Diseases. PMID 30010950 DOI: 10.1093/Infdis/Jiy377  0.377
2018 Gunn BM, Jones JE, Shabman RS, Whitmore AC, Sarkar S, Blevins LK, Morrison TE, Heise MT. Ross River virus envelope glycans contribute to disease through activation of the host complement system. Virology. 515: 250-260. PMID 29324290 DOI: 10.1016/J.Virol.2017.12.022  0.622
2014 Stoermer Burrack KA, Hawman DW, Jupille HJ, Oko L, Minor M, Shives KD, Gunn BM, Long KM, Morrison TE. Attenuating mutations in nsP1 reveal tissue-specific mechanisms for control of Ross River virus infection. Journal of Virology. 88: 3719-32. PMID 24429363 DOI: 10.1128/Jvi.02609-13  0.468
2013 Long KM, Whitmore AC, Ferris MT, Sempowski GD, McGee C, Trollinger B, Gunn B, Heise MT. Dendritic cell immunoreceptor regulates Chikungunya virus pathogenesis in mice. Journal of Virology. 87: 5697-706. PMID 23487448 DOI: 10.1128/Jvi.01611-12  0.663
2012 Gunn BM, Morrison TE, Whitmore AC, Blevins LK, Hueston L, Fraser RJ, Herrero LJ, Ramirez R, Smith PN, Mahalingam S, Heise MT. Mannose binding lectin is required for alphavirus-induced arthritis/myositis. Plos Pathogens. 8: e1002586. PMID 22457620 DOI: 10.1371/Journal.Ppat.1002586  0.669
2011 Morrison TE, Oko L, Montgomery SA, Whitmore AC, Lotstein AR, Gunn BM, Elmore SA, Heise MT. A mouse model of chikungunya virus-induced musculoskeletal inflammatory disease: evidence of arthritis, tenosynovitis, myositis, and persistence. The American Journal of Pathology. 178: 32-40. PMID 21224040 DOI: 10.1016/J.Ajpath.2010.11.018  0.655
2011 Jupille HJ, Oko L, Stoermer KA, Heise MT, Mahalingam S, Gunn BM, Morrison TE. Mutations in nsP1 and PE2 are critical determinants of Ross River virus-induced musculoskeletal inflammatory disease in a mouse model. Virology. 410: 216-27. PMID 21131014 DOI: 10.1016/J.Virol.2010.11.012  0.599
2010 Wang S, Li Y, Scarpellini G, Kong W, Shi H, Baek CH, Gunn B, Wanda SY, Roland KL, Zhang X, Senechal-Willis P, Curtiss R. Salmonella Vaccine Vectors Displaying Delayed Antigen Synthesis In Vivo To Enhance Immunogenicity Infection and Immunity. 78: 3969-3980. PMID 20605977 DOI: 10.1128/Iai.00444-10  0.396
2010 Curtiss R, Xin W, Li Y, Kong W, Wanda SY, Gunn B, Wang S. New technologies in using recombinant attenuated Salmonella vaccine vectors. Critical Reviews in Immunology. 30: 255-270. PMID 20370633 DOI: 10.1615/Critrevimmunol.V30.I3.30  0.378
2010 Torres-Escobar A, Juárez-Rodríguez MD, Gunn BM, Branger CG, Tinge SA, Curtiss R. Fine-tuning synthesis of Yersinia pestis LcrV from runaway-like replication balanced-lethal plasmid in a Salmonella enterica serovar typhimurium vaccine induces protection against a lethal Y. pestis challenge in mice. Infection and Immunity. 78: 2529-43. PMID 20308296 DOI: 10.1128/Iai.00005-10  0.39
2010 Gunn BM, Wanda SY, Burshell D, Wang C, Curtiss R. Construction of recombinant attenuated Salmonella enterica serovar typhimurium vaccine vector strains for safety in newborn and infant mice. Clinical and Vaccine Immunology : Cvi. 17: 354-62. PMID 20053874 DOI: 10.1128/Cvi.00412-09  0.406
2010 Shi H, Wang S, Roland KL, Gunn BM, Curtiss R. Immunogenicity of a live recombinant Salmonella enterica serovar typhimurium vaccine expressing pspA in neonates and infant mice born from naive and immunized mothers. Clinical and Vaccine Immunology : Cvi. 17: 363-71. PMID 20053873 DOI: 10.1128/Cvi.00413-09  0.417
2009 Hall JD, Kurtz SL, Rigel NW, Gunn BM, Taft-Benz S, Morrison JP, Fong AM, Patel DD, Braunstein M, Kawula TH. The impact of chemokine receptor CX3CR1 deficiency during respiratory infections with Mycobacterium tuberculosis or Francisella tularensis. Clinical and Experimental Immunology. 156: 278-84. PMID 19250281 DOI: 10.1111/J.1365-2249.2009.03882.X  0.458
2009 Li Y, Wang S, Scarpellini G, Gunn B, Xin W, Wanda SY, Roland KL, Curtiss R. Evaluation of new generation Salmonella enterica serovar Typhimurium vaccines with regulated delayed attenuation to induce immune responses against PspA Proceedings of the National Academy of Sciences of the United States of America. 106: 593-598. PMID 19114649 DOI: 10.1073/Pnas.0811697106  0.419
2009 Curtiss R, Wanda SY, Gunn BM, Zhang X, Tinge SA, Ananthnarayan V, Mo H, Wang S, Kong W. Salmonella enterica serovar typhimurium strains with regulated delayed attenuation in vivo. Infection and Immunity. 77: 1071-82. PMID 19103774 DOI: 10.1128/Iai.00693-08  0.454
2008 Hall JD, Woolard MD, Gunn BM, Craven RR, Taft-Benz S, Frelinger JA, Kawula TH. Infected-host-cell repertoire and cellular response in the lung following inhalation of Francisella tularensis Schu S4, LVS, or U112. Infection and Immunity. 76: 5843-52. PMID 18852251 DOI: 10.1128/Iai.01176-08  0.443
2008 Frandsen JL, Gunn B, Muratoglu S, Fossett N, Newfeld SJ. Salmonella pathogenesis reveals that BMP signaling regulates blood cell homeostasis and immune responses in Drosophila. Proceedings of the National Academy of Sciences of the United States of America. 105: 14952-7. PMID 18815369 DOI: 10.1073/Pnas.0808208105  0.339
2008 Li Y, Wang S, Xin W, Scarpellini G, Shi Z, Gunn B, Roland KL, Curtiss R. A sopB Deletion Mutation Enhances the Immunogenicity and Protective Efficacy of a Heterologous Antigen Delivered by Live Attenuated Salmonella enterica Vaccines Infection and Immunity. 76: 5238-5246. PMID 18765737 DOI: 10.1128/Iai.00720-08  0.459
2008 Bollen WS, Gunn BM, Mo H, Lay MK, Curtiss R. Presence of wild-type and attenuated Salmonella enterica strains in brain tissues following inoculation of mice by different routes. Infection and Immunity. 76: 3268-72. PMID 18474649 DOI: 10.1128/Iai.00244-08  0.426
Show low-probability matches.